Yarlagadda S. Babu, Chief Discovery Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 20,000 shares at $17.16 ($343K) on 2022-03-07, disclosed to the SEC on 2022-03-09.
Seasonal sale ($343k) by Chief Discovery Officer — this insider has traded BCRX in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BCRX | BUY | 2019-11-18 | $36K | — | Filing → |
| BCRX | SELL | 2016-08-29 | $244K | — | Filing → |
| BCRX | SELL | 2015-03-20 | $123K | — | Filing → |